Michalik Michał, Samet Alfred, Dmowska-Koroblewska Agnieszka, Podbielska-Kubera Adrianna, Waszczuk-Jankowska Małgorzata, Struck-Lewicka Wiktoria, Markuszewski Michał J
Medical Center MML, Bagno 2, 00-112 Warsaw, Poland.
Department of Biopharmaceutics and Pharmacodynamics, Medical University of Gdańsk, Hallera 107, 80-416 Gdańsk, Poland.
J Pers Med. 2020 Nov 26;10(4):245. doi: 10.3390/jpm10040245.
Chronic rhinosinusitis (CRS) is an inflammatory disease of the paranasal sinuses. It is defined as the presence of a minimum of two out of four main symptoms such as hyposmia, facial pain, nasal blockage, and discharge, which last for 8-12 weeks. CRS significantly impairs a patient's quality of life. It needs special treatment mainly focusing on preventing local infection/inflammation with corticosteroid sprays or improving sinus drainage using nasal saline irrigation. When other treatments fail, endoscopic sinus surgery is considered an effective option. According to the state-of-the-art knowledge of CRS, there is more evidence suggesting that it is more of an inflammatory disease than an infectious one. This condition is also treated as a multifactorial inflammatory disorder as it may be triggered by various factors, such as bacterial or fungal infections, airborne irritants, defects in innate immunity, or the presence of concomitant diseases. Due to the incomplete understanding of the pathological processes of CRS, there is a continuous search for new indicators that are directly related to the pathogenesis of this disease-e.g., in the field of systems biology. The studies adopting systems biology search for possible factors responsible for the disease at genetic, transcriptomic, proteomic, and metabolomic levels. The analyses of the changes in the genome, transcriptome, proteome, and metabolome may reveal the dysfunctional pathways of inflammatory regulation and provide a clear insight into the pathogenesis of this disease. Therefore, in the present paper, we have summarized the state-of-the-art knowledge of the application of systems biology in the pathology and development of CRS.
慢性鼻-鼻窦炎(CRS)是鼻窦的一种炎症性疾病。它被定义为至少出现嗅觉减退、面部疼痛、鼻塞和流涕这四种主要症状中的两种,且持续8 - 12周。CRS会显著损害患者的生活质量。它需要特殊治疗,主要侧重于使用皮质类固醇喷雾剂预防局部感染/炎症,或使用鼻腔生理盐水冲洗改善鼻窦引流。当其他治疗方法失败时,鼻窦内窥镜手术被认为是一种有效的选择。根据关于CRS的最新知识,有更多证据表明它更多是一种炎症性疾病而非感染性疾病。这种病症也被视为一种多因素炎症性疾病,因为它可能由多种因素引发,如细菌或真菌感染、空气传播的刺激物、先天免疫缺陷或伴发疾病的存在。由于对CRS病理过程的理解不完整,人们一直在持续寻找与该疾病发病机制直接相关的新指标——例如在系统生物学领域。采用系统生物学的研究在基因、转录组、蛋白质组和代谢组水平上寻找可能导致该疾病的因素。对基因组、转录组、蛋白质组和代谢组变化的分析可能揭示炎症调节的功能失调途径,并为该疾病的发病机制提供清晰的见解。因此,在本文中,我们总结了系统生物学在CRS病理和发展中的应用的最新知识。